AZN : Summary for Astrazeneca PLC Common Stock - Yahoo Finance

U.S. Markets closed

AstraZeneca PLC (AZN)

NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
27.07-0.84 (-3.01%)
At close: 4:00PM EST

27.09 0.02 (0.07%)
After hours: 4:10PM EST

People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close27.91
Bid0.00 x
Ask0.00 x
Day's Range26.86 - 27.41
52 Week Range25.55 - 35.04
Avg. Volume7,633,472
Market Cap68.23B
PE Ratio (TTM)30.94
Earnings DateN/A
Dividend & Yield0.90 (3.16%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters4 hours ago

    Bristol-Myers shares fall on lung cancer timeline setback

    Lung cancer is by far the biggest oncology market and a handful of companies have been jockeying for position in the battle to become dominant in initial, or first-line, treatment, and to provide much-needed combination therapies. Merck shares rose 3.8 percent to $62.60, while Bristol fell to $50.04. Bristol-Myers had suggested it would seek a path to swift approval of an Opdivo/Yervoy combination in first-line non-small cell lung cancer (NSCLC) only to reverse course after reviewing available data.

  • Accesswire8 hours ago

    Blog Coverage AbbVie Received FDA Approval for Treatment for Marginal Zone Lymphoma

    Upcoming AWS Coverage on AstraZeneca LONDON, UK / ACCESSWIRE / January 20, 2017 / Active Wall St. blog coverage looks at the headline from AbbVie Inc. (NYSE: ABBV ) as the Company announced on January ...

  • Financial Timesyesterday

    [$$] GSK appoints AstraZeneca executive as global head of pharma

    GlaxoSmithKline has poached its new global head of pharmaceuticals from rival AstraZeneca, marking a change of guard at Britain's biggest drugmaker as it prepares for the arrival of its new chief executive. ...